• Shopping cart is empty.

    The International Society for Aerosols in Medicine

    Bernhard Müllinger

    Bernhard Müllinger


    Bernhard Müllinger is Vice President Inhalation Technology at Vectura GmbH. His primary research and development focuses are new drug products and new inhalation technologies, which improve respiratory aerosol delivery. For 25 years, he has worked in interdisciplinary development teams on inhalation device development, deposition modelling, aerosol delivery strategies, patient compliance management and in vitro testing of inhalation products.

    In clinical research and development programs, he was and still is working on improvement of inhalation treatment of asthma and pulmonary hypertension, vaccination, influenza, cystic fibrosis and COPD, and worked here with small molecules, peptides and proteins.

    Bernhard started with aerosols in 1995 at the Helmholtz-Zentrum Munich with Prof. Joachim Heyder working on optimization of particle deposition and environmental aerosol research.From there he moved to a research group at Asklepios Clinics studying new pulmonary diagnostic technologies. He joined Dr. Gerhard Scheuch in 2000 to build up a respiratory specialty CRO and a respiratory drug/device development company, which led to successful products and several spin-off companies.

    He has been a member of ISAM since 2002.